Advertisement
ResearchIn-Press PreviewCell biologyClinical ResearchPulmonology
Open Access |
10.1172/JCI201541
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Joo, N. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Birket, S. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Keith, J. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by
Ianowski, J.
in:
PubMed
|
Google Scholar
|
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Luan, X. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Spano, J. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Bollyky, J. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Dobry, M. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Sabater, J. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Williams, R. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by
Engelhardt, J.
in:
PubMed
|
Google Scholar
|
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by Wine, J. in: PubMed | Google Scholar
1The Cystic Fibrosis Research Laboratory, Stanford University, Stanford, United States of America
2Department of Medicine, University of Alabama at Birmingham, Birmingham, United States of America
3Department of Anatomy Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
4Center for Excellence in Pulmonary Biology, Stanford University, Stanford, United States of America
5Department of Medicine, Stanford University, Stanford, United States of America
6Innovative Medicines Accelerator Program, Stanford University, Stanford, United States of America
7Friedman Advanced Research Institute, Mount Sinai Medical Center, Miami, United States of America
8Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States of America
Find articles by
Milla, C.
in:
PubMed
|
Google Scholar
|
Published April 2, 2026 - More info
Mucociliary clearance (MCC) is an innate defense mechanism that normally keeps airways clean but is dysfunctional in cystic fibrosis (CF) and other muco-obstructive pulmonary diseases. Previously we discovered that activating adenyl cyclase in combination with a cholinergic agonist increased MCC velocity (MCCV) synergistically in ex vivo WT and CF ferret and WT piglets. The present study extends and underpins our earlier findings by showing for the first time, in vivo synergistic MCC in WT rats and in CF sheep models and CF rats using inhalable β-adrenergic and cholinergic drugs approved for human use when delivered to the apical surface and a single dose is tolerated by humans. As for mechanisms via ex vivo experiments, we show the combined agonists increased net fluid secretion mainly by stimulating gland secretion and by inhibiting surface absorption, consequently increased ASL depth. They also increased net base secretion and increased ciliary beat frequency. Additional ex vivo and in vitro experiments show that the combined agonists have additive effects when combined with highly effective CF transmembrane conductance regulator (CFTR) modulator therapy (HEMT). The synergistic increase in MCCV induced by this combination of agonists offers therapeutic potential for treating muco-obstructive pulmonary diseases including CF.